Bioline Rx (BLRX) Revenue (2009 - 2026)
Bioline Rx (BLRX) revenue from Dec 31, 2009 to Mar 31, 2026. The TTM Bioline Rx (BLRX) revenue is $1.41M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Bioline Rx (BLRX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -93.69% |
| All Time TTM | -18.50% |
Annual Revenue change of Bioline Rx (BLRX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $480K | -59.66% |
| 2025 | $1.19M | -95.89% |
| 2024 | $29M | +502.92% |
| 2023 | $4.80M | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | -100.00% |
| 2013 | $113M | N/A |
| 2012 | $113M | +77.06% |
| 2011 | $64M | +100.41% |
| 2010 | $32M | +96.00% |
| 2009 | $16M | N/A |
| 2008 | $0 | N/A |